While inflation normalizes across the US economy, it continues to significantly influence the US Food and Drug Administration’s user fee programs.
Key Takeaways
-
Inflation continued to increase its influence over user fees in the most recent calculations.
Fiscal year 2025 user fee calculations indicate that revenue target increases to account for inflation continued to rise. The dollars...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?